PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $421,434 | +21.4% | 39,683 | +4.3% | 0.00% | – |
| Q4 2023 | $347,269 | -12.0% | 38,036 | -0.0% | 0.00% | – |
| Q3 2023 | $394,454 | -30.2% | 38,038 | -3.6% | 0.00% | -100.0% |
| Q2 2023 | $565,125 | +375.1% | 39,464 | +136.9% | 0.00% | – |
| Q1 2023 | $118,960 | -31.4% | 16,661 | +7.9% | 0.00% | – |
| Q4 2022 | $173,292 | +44.4% | 15,445 | +42.9% | 0.00% | – |
| Q3 2022 | $120,000 | +36.4% | 10,812 | +4.8% | 0.00% | – |
| Q2 2022 | $88,000 | -67.5% | 10,321 | +22.4% | 0.00% | – |
| Q3 2021 | $271,000 | +21.0% | 8,429 | +27.7% | 0.00% | – |
| Q2 2021 | $224,000 | +10.9% | 6,599 | +23.0% | 0.00% | – |
| Q1 2021 | $202,000 | -23.5% | 5,366 | -32.3% | 0.00% | – |
| Q4 2020 | $264,000 | – | 7,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 7,464,572 | $76,885,092 | 22.93% |
| Propel Bio Management, LLC | 869,927 | $8,960,248 | 5.81% |
| Catalys Pacific, LLC | 721,962 | $7,436,208 | 5.61% |
| Checkpoint Capital L.P. | 875,000 | $9,012,500 | 5.43% |
| Frazier Life Sciences Management, L.P. | 10,109,279 | $104,125,574 | 4.87% |
| Carlyle Group Inc. | 3,496,808 | $35,842,282 | 3.40% |
| Decheng Capital LLC | 850,000 | $8,755,000 | 2.68% |
| Saturn V Capital Management LP | 593,306 | $6,111,052 | 2.31% |
| ORACLE INVESTMENT MANAGEMENT INC | 225,000 | $2,317,500 | 2.16% |
| Ghost Tree Capital, LLC | 600,000 | $6,180,000 | 1.94% |